Gelonghui, December 22, 丨 Imperial International Investment (00928.HK) announced that on December 18, 2023, the seller (a wholly-owned subsidiary of the company) signed a sale agreement with the buyer. Based on this, the company agreed to sell sales rights to the buyer at a total cost of RMB 23.6 million. Sales equity accounts for 65% of the registered capital of the target company, Beijing Lianhe Health Management Co., Ltd.
The target group is mainly engaged in the development of large health markets in China, such as intelligent medical examinations, distribution of medical supplies and equipment, Internet medical technology, and medical research and development for public health care in rural areas.
The directors believe that the sale is a good opportunity to realise sales rights at a price higher than its valuation and use the net proceeds to supplement the general working capital of the Group's operations and existing business.